drug protocol number

ID-076A301 / SOS-AMI

drug sponsor

Viatris Innovation GmbH / IQVIA

drug study

(ACT-246475) is a 2-phenyl-pyrimidine derivative selatogrel

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh).

drug status

Ongoing

drug phase